Thermo Fisher Scientific Inc. Share Price NEO Exchange
Equities
TMO
CA88355G1000
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.39 CAD | +0.99% | +3.80% | 0.00% |
Sales 2024 * | 43.01B 58.58B 3,401B | Sales 2025 * | 46.08B 62.77B 3,644B | Capitalization | 227B 309B 17,954B |
---|---|---|---|---|---|
Net income 2024 * | 6.11B 8.32B 483B | Net income 2025 * | 7B 9.54B 554B | EV / Sales 2024 * | 5.84 x |
Net Debt 2024 * | 23.99B 32.68B 1,897B | Net Debt 2025 * | 19.18B 26.13B 1,517B | EV / Sales 2025 * | 5.34 x |
P/E ratio 2024 * |
37.6
x | P/E ratio 2025 * |
32
x | Employees | 122,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.27% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
1 day | +0.99% | ||
1 week | +3.80% | ||
Current month | +4.19% | ||
1 month | +3.32% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
Director of Finance/CFO | 57 | 31/05/01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
C. Harris
BRD | Director/Board Member | 67 | 29/03/12 |
Ruby Chandy
BRD | Director/Board Member | 62 | 28/02/22 |
Date | Price | Change | Volume |
---|---|---|---|
14/05/24 | 22.39 | +0.99% | 2,394 |
13/05/24 | 22.17 | -0.63% | 300 |
10/05/24 | 22.31 | +2.86% | 611 |
09/05/24 | 21.69 | +0.56% | 238 |
07/05/24 | 21.57 | +0.09% | 157 |
End-of-day quote NEO Exchange, May 13, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.07% | 192B | |
+13.88% | 136B | |
+27.12% | 108B | |
+0.57% | 64.07B | |
+13.39% | 52.1B | |
+6.74% | 51.87B | |
+8.81% | 44.33B | |
+4.14% | 36.75B | |
+25.48% | 31.71B |
- Stock Market
- Equities
- TMO Stock
- TMO Stock